BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 21676946)

  • 1. The SUMO E3-ligase PIAS1 couples reactive oxygen species-dependent JNK activation to oxidative cell death.
    Leitao BB; Jones MC; Brosens JJ
    FASEB J; 2011 Oct; 25(10):3416-25. PubMed ID: 21676946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of protein inhibitor of activated STAT1 (PIAS1) by MAPK-activated protein kinase-2 inhibits endothelial inflammation via increasing both PIAS1 transrepression and SUMO E3 ligase activity.
    Heo KS; Chang E; Takei Y; Le NT; Woo CH; Sullivan MA; Morrell C; Fujiwara K; Abe J
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):321-9. PubMed ID: 23202365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein inhibitor of activated STAT 1 (PIAS1) is identified as the SUMO E3 ligase of CCAAT/enhancer-binding protein β (C/EBPβ) during adipogenesis.
    Liu Y; Zhang YD; Guo L; Huang HY; Zhu H; Huang JX; Liu Y; Zhou SR; Dang YJ; Li X; Tang QQ
    Mol Cell Biol; 2013 Nov; 33(22):4606-17. PubMed ID: 24061474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PIAS1 binds p300 and behaves as a coactivator or corepressor of the transcription factor c-Myb dependent on SUMO-status.
    Ledsaak M; Bengtsen M; Molværsmyr AK; Fuglerud BM; Matre V; Eskeland R; Gabrielsen OS
    Biochim Biophys Acta; 2016 May; 1859(5):705-18. PubMed ID: 27032383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transcriptional activity of co-activator AIB1 is regulated by the SUMO E3 ligase PIAS1.
    Li S; Yang C; Hong Y; Bi H; Zhao F; Liu Y; Ao X; Pang P; Xing X; Chang AK; Xiao L; Zhang Y; Wu H
    Biol Cell; 2012 May; 104(5):287-96. PubMed ID: 22283414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SUMO Ligase Protein Inhibitor of Activated STAT1 (PIAS1) Is a Constituent Promyelocytic Leukemia Nuclear Body Protein That Contributes to the Intrinsic Antiviral Immune Response to Herpes Simplex Virus 1.
    Brown JR; Conn KL; Wasson P; Charman M; Tong L; Grant K; McFarlane S; Boutell C
    J Virol; 2016 Jul; 90(13):5939-5952. PubMed ID: 27099310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linking nuclear matrix-localized PIAS1 to chromatin SUMOylation via direct binding of histones H3 and H2A.Z.
    Chen Z; Zhang Y; Guan Q; Zhang H; Luo J; Li J; Wei W; Xu X; Liao L; Wong J; Li J
    J Biol Chem; 2021 Oct; 297(4):101200. PubMed ID: 34537242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing of the JNK pathway maintains progesterone receptor activity in decidualizing human endometrial stromal cells exposed to oxidative stress signals.
    Leitao B; Jones MC; Fusi L; Higham J; Lee Y; Takano M; Goto T; Christian M; Lam EW; Brosens JJ
    FASEB J; 2010 May; 24(5):1541-51. PubMed ID: 20026682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transcriptional repression activity of KyoT2 on the Notch/RBP-J pathway is regulated by PIAS1-catalyzed SUMOylation.
    Wang J; Qin H; Liang J; Zhu Y; Liang L; Zheng M; Han H
    J Mol Biol; 2007 Jun; 370(1):27-38. PubMed ID: 17509614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative SUMO proteomics identifies PIAS1 substrates involved in cell migration and motility.
    Li C; McManus FP; Plutoni C; Pascariu CM; Nelson T; Alberici Delsin LE; Emery G; Thibault P
    Nat Commun; 2020 Feb; 11(1):834. PubMed ID: 32047143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SUMO ligase PIAS1 regulates UV-induced apoptosis by recruiting Daxx to SUMOylated foci.
    Sudharsan R; Azuma Y
    J Cell Sci; 2012 Dec; 125(Pt 23):5819-29. PubMed ID: 22976298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a non-covalent ternary complex formed by PIAS1, SUMO1, and UBC9 proteins involved in transcriptional regulation.
    Mascle XH; Lussier-Price M; Cappadocia L; Estephan P; Raiola L; Omichinski JG; Aubry M
    J Biol Chem; 2013 Dec; 288(51):36312-27. PubMed ID: 24174529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Myc is targeted to the proteasome for degradation in a SUMOylation-dependent manner, regulated by PIAS1, SENP7 and RNF4.
    González-Prieto R; Cuijpers SA; Kumar R; Hendriks IA; Vertegaal AC
    Cell Cycle; 2015; 14(12):1859-72. PubMed ID: 25895136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Necdin promotes ubiquitin-dependent degradation of PIAS1 SUMO E3 ligase.
    Gur I; Fujiwara K; Hasegawa K; Yoshikawa K
    PLoS One; 2014; 9(6):e99503. PubMed ID: 24911587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SUMO3 modification by PIAS1 modulates androgen receptor cellular distribution and stability.
    Yang N; Liu S; Qin T; Liu X; Watanabe N; Mayo KH; Li J; Li X
    Cell Commun Signal; 2019 Nov; 17(1):153. PubMed ID: 31752909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PIAS1 and TIF1γ collaborate to promote SnoN SUMOylation and suppression of epithelial-mesenchymal transition.
    Chanda A; Ikeuchi Y; Karve K; Sarkar A; Chandhoke AS; Deng L; Bonni A; Bonni S
    Cell Death Differ; 2021 Jan; 28(1):267-282. PubMed ID: 32770107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDKN2A deregulation in fatty liver disease and its accelerative role in the process of lipogenesis.
    Zhang Z; Wen H; Peng B; Weng J; Zeng F
    FASEB J; 2021 Apr; 35(4):e21230. PubMed ID: 33769609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SUMO E3-ligase PIAS1 regulates the tumor suppressor PML and its oncogenic counterpart PML-RARA.
    Rabellino A; Carter B; Konstantinidou G; Wu SY; Rimessi A; Byers LA; Heymach JV; Girard L; Chiang CM; Teruya-Feldstein J; Scaglioni PP
    Cancer Res; 2012 May; 72(9):2275-84. PubMed ID: 22406621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SUMO E3 ligase PIAS1 is a potential biomarker indicating stress susceptibility.
    Lin HY; Liu YS; Huang CY; Cathomas F; Liu K; Wang J; Cheng HT; Lai SW; Liu YC; Chen CJ; Lin C; Lu DY
    Psychoneuroendocrinology; 2020 Oct; 120():104800. PubMed ID: 32688147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PIAS1 modulates striatal transcription, DNA damage repair, and SUMOylation with relevance to Huntington's disease.
    Morozko EL; Smith-Geater C; Monteys AM; Pradhan S; Lim RG; Langfelder P; Kachemov M; Kulkarni JA; Zaifman J; Hill A; Stocksdale JT; Cullis PR; Wu J; Ochaba J; Miramontes R; Chakraborty A; Hazra TK; Lau A; St-Cyr S; Orellana I; Kopan L; Wang KQ; Yeung S; Leavitt BR; Reidling JC; Yang XW; Steffan JS; Davidson BL; Sarkar PS; Thompson LM
    Proc Natl Acad Sci U S A; 2021 Jan; 118(4):. PubMed ID: 33468657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.